Skip to main content

Osteoporosis

  • Chapter
  • First Online:
Advanced Practice in Endocrinology Nursing
  • 2180 Accesses

Abstract

Osteoporosis is considered as the most common bone disease in humans and represents a major public health issue as its prevalence is increasing with an aging population. Osteoporosis leads to nearly nine million fractures annually worldwide. It is a silent disease and its clinical significance lies in the fractures that arise from it. These fractures are usually sustained following minimal trauma also known as fragility fractures. It is estimated that more than one-third of adult women and one in five men will sustain one or more fragility fractures in their lifetime. Osteoporotic fragility fractures can cause substantial pain and severe disability, often leading to reduced quality of life. Additionally, hip and vertebral fractures are associated with decreased life expectancy. Hip fractures in particular, always requires hospitalization, is fatal in 20% of cases and causes permanent disability in 50% of those affected with only 30% of patients fully recover.

The substantial cost of fragility fractures is causing a significant toll on the already limited healthcare budget. In America, the cost of osteoporosis-related fractures was estimated at $17 billion in 2015 and is estimated to double and even triple by the year 2040. There are a number of effective therapies available for the prevention of fragility fracture in people thought to be at risk, or to prevent further fractures in those who have already sustained one or more fragility fractures. However, in order to effectively reduce the personal, medical, and economic burden of osteoporosis-related fractures, a robust system of fracture prevention, identification, and treatment of those who are at risk should be implemented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

25(OH)D:

25-hydroxyvitamin D

AFF:

Atypical femoral fracture

BMD:

Bone mineral density

BMI:

Body mass index

BTM:

Bone turnover marker

CT:

Computed tomography

DH:

Department of Health, UK

DXA:

Dual-energy X-ray absorptiometry

EMA:

European Medicines Agency

EU:

European Union

FRAX:

Fracture risk assessment tool

GH:

Growth hormone

GI:

Gastrointestinal

GIO:

Glucocorticoid-induced osteoporosis

HR-pQCT:

High resolution peripheral quantitative computed tomography

HRT:

Hormone replacement therapy

IGF-1:

Insulin-like growth hormone factor-1

IL:

Interleukin

IU:

International unit

L:

Liter

min:

Minutes

ml/mL:

Milliliter

MRI:

Magnetic resonance imaging

ng:

Nanogram

NICE:

National Institute for Health and Care Excellence

nmol:

Nanomole

NOF:

National Osteoporosis Foundation

ONJ:

Osteonecrosis of the jaw

pDXA:

Peripheral dual-energy X-ray absorptiometry

pQCT:

Peripheral quantitative computed tomography

PTH:

Parathyroid hormone

QCT:

Quantitative computed tomography

QUS:

Quantitative ultrasonometry

RANKL:

Receptor Activator of Nuclear factor Kappa-B Ligand

SD:

Standard deviation

TGF:

Transforming growth factor

UK:

United Kingdom of Great Britain

USA:

United States of America

VFA:

Vertebral fracture assessment

VTE:

Venous thromboembolism

WHO:

World Health Organization

References

  • Abrahamsen B, Van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int [online]. 2009;20(10):1633–50.

    CAS  Google Scholar 

  • Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ. Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American society for bone and mineral research. J Bone Miner Res [online]. 2016;31(1):16–35.

    CAS  Google Scholar 

  • Allende-Vigo MZ. The use of biochemical markers of bone turnover in osteoporosis. Puerto Rico health sciences journal [online]. 2007;26(2):91–5.

    Google Scholar 

  • Aspray TJ, Bowring C, Fraser W, Gittoes N, Javaid MK, Macdonald H, Patel S, Selby P, Tanna N, Francis RM. National osteoporosis society vitamin D guideline summary. Age Ageing [online]. 2014;43(5):592–5.

    Google Scholar 

  • Bailey D, McKay H, Mirwald R, Crocker P, Faulkner R. A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study. J Bone Miner Res [online]. 1999;14(10):1672–9.

    CAS  Google Scholar 

  • Bailey DA, Martin AD, McKay HA, Whiting S, Mirwald R. Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Miner Res [online]. 2000;15(11):2245–50.

    CAS  Google Scholar 

  • Bauer DC, Black D, Ensrud K, Thompson D, Hochberg M, Nevitt M, Musliner T, Freedholm D. Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial. Arch Intern Med [online]. 2000;160(4):517–25.

    CAS  Google Scholar 

  • Bethel M. Osteoporosis 14 November 2017-last update. Medscape. 2017. https://emedicine.medscape.com/article/330598-overview#showall. Accessed 2 Jan 2018.

  • Bilezikian JP. Osteonecrosis of the jaw-do bisphosphonates pose a risk? N Engl J Med [online]. 2006;355(22):2278.

    CAS  Google Scholar 

  • Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med [online]. 2004;116(9):634–9.

    CAS  Google Scholar 

  • Blake GM, Fogelman I. Role of dual-energy X-ray absorptiometry in the diagnosis and treatment of osteoporosis. J Clin Densitom. 2007;10(1):102–10.

    PubMed  Google Scholar 

  • Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA [online]. 2009;301(5):513–21.

    CAS  Google Scholar 

  • BMJ. Osteoporosis. BMJ Best Practice. 2018. https://bestpractice.bmj.com/topics/en-gb/85.

  • Bolland MJ, Leung W, Tai V, Bastin S, Gamble GD, Grey A, Reid IR. Calcium intake and risk of fracture: systematic review. BMJ (Clinical research ed.) [online]. 2015;351:h4580.

    Google Scholar 

  • Bono CM, Einhorn TA. Overview of osteoporosis: pathophysiology and determinants of bone strength. Eur Spine J [online]. 2003;12(2):S90–6.

    PubMed Central  Google Scholar 

  • Burge RT, Worley D, Johansen A, Bhattacharyya S, Bose U. The cost of osteoporotic fractures in the UK: projections for 2000–2020. J Med Econ [online]. 2001;4(1–4):51–62.

    Google Scholar 

  • Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res [online]. 2007;22(3):465–75.

    Google Scholar 

  • Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2016. Endocr Pract [online]. 2016;22(s4):1–42.

    Google Scholar 

  • Colón-Emeric C, Kuchibhatla M, Pieper C, Hawkes W, Fredman L, Magaziner J, Zimmerman S, Lyles KW. The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int [online]. 2003;14(11):879–83.

    Google Scholar 

  • Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P, Wilkins M, National Osteoporosis Guideline Group (NOGG). Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas [online]. 2009;62(2):105–8.

    CAS  Google Scholar 

  • Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, Hope S, Kanis J, McCloskey E, Poole K. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos [online]. 2017;12(1):43.

    CAS  Google Scholar 

  • Cooper C, Melton LJ III. Epidemiology of osteoporosis. Trends Endocrinol Metab. 1992;3(6):224–9.

    CAS  PubMed  Google Scholar 

  • Cooper C, Atkinson EJ, Jacobsen SJ, O’Fallon WM, Melton LJ III. Population-based study of survival after osteoporotic fractures. Am J Epidemiol [online]. 1993;137(9):1001–5.

    CAS  Google Scholar 

  • Cosman F, De Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S, Lindsay R. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int [online]. 2014;25(10):2359–81.

    CAS  Google Scholar 

  • Daniell HW. Osteoporosis of the slender smoker. Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Arch Intern Med [online]. 1976;136(3):298–304.

    CAS  Google Scholar 

  • De Laet CE, Van Hout BA, Burger H, Weel AE, Hofman A, Pols HA. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res [online]. 1998;13(10):1587–93.

    Google Scholar 

  • Department of Health. Hospital episode statistics (England). 2006.

    Google Scholar 

  • European Medicines Agency (EMA). Protelos/Osseor to remain available but with further restrictions. London. 2014. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Protelos_and_Osseor/human_referral_prac_000025.jsp&mid=WC0b01ac05805c516f.

  • Frost HM. Bone remodeling and its relationship to metabolic bone diseases [online]. Springfield: Charles C. Thomas Publisher; 1973.

    Google Scholar 

  • Gallacher S, Gallagher A, McQuillian C, Mitchell P, Dixon T. The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures. Osteoporos Int [online]. 2007;18(2):185–92.

    CAS  Google Scholar 

  • Gallagher JC, Sai AJ. Bone: is screening for secondary causes of osteoporosis worthwhile? Nat Rev Endocrinol [online]. 2010;6(7):360.

    Google Scholar 

  • Gedmintas L, Solomon DH, Kim SC. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J Bone Miner Res [online]. 2013;28(8):1729–37.

    CAS  Google Scholar 

  • Giampietro PF, McCarty C, Mukesh B, McKiernan F, Wilson D, Shuldiner A, Liu J, LeVasseur J, Ivacic L, Kitchner T, Ghebranious N. The role of cigarette smoking and statins in the development of postmenopausal osteoporosis: a pilot study utilizing the Marshfield Clinic Personalized Medicine Cohort. Osteoporos Int. 2010;21(3):467–77.

    CAS  PubMed  Google Scholar 

  • Gillespie WJ, Gillespie LD, Parker MJ Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev [online]. 2010;(10):CD001255.

    Google Scholar 

  • Harvey N, Dennison E, Cooper C. Osteoporosis: impact on health and economics. Nat Rev Rheumatol [online]. 2010;6(2):99.

    Google Scholar 

  • Hernlund E, Svedbom A, IvergÃ¥rd M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos [online]. 2013;8(1–2):136.

    CAS  PubMed Central  Google Scholar 

  • Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab [online]. 2005;90(6):3215–24.

    CAS  Google Scholar 

  • Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab [online]. 2011;96(7):1911–30. https://academic.oup.com/jcem/article/96/7/1911/2833671. Accessed 23 June 2018.

    CAS  Google Scholar 

  • International Society for Clinical Densitometry (ISCD). 2015 ISCD official positions—adult June 18, 2015-last update Middletown, CT: ISCD. 2015. https://www.iscd.org/official-positions/2015-iscd-official-positions-adult/. Accessed 21 Apr 2018.

  • Johnell O, Kanis J. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int [online]. 2006;17(12):1726–33.

    CAS  Google Scholar 

  • Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D. Predictive value of BMD for hip and other fractures. J Bone Miner Res [online]. 2005;20(7):1185–94.

    Google Scholar 

  • Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res [online]. 1994;9(8):1137–41.

    CAS  Google Scholar 

  • Kanis J, Johnell O, Oden A, Sernbo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B. Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int [online]. 2000;11(8):669–74.

    CAS  Google Scholar 

  • Kanis J, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int [online]. 2001a;12(12):989–95.

    CAS  Google Scholar 

  • Kanis J, Oden A, Johnell O, Jonsson B, De Laet C, Dawson A. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int [online]. 2001b;12(5):417–27.

    CAS  Google Scholar 

  • Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res [online]. 2002;17(7):1237–44.

    Google Scholar 

  • Kanis J, Oden A, Johnell O, De Laet C, Jonsson B, Oglesby A. The components of excess mortality after hip fracture. Bone [online]. 2003;32(5):468–73.

    CAS  Google Scholar 

  • Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N. Assessment of fracture risk. Osteoporos Int [online]. 2005a;16(6):581–9.

    Google Scholar 

  • Kanis JA, Johnell O, Odén A, Johansson H, De Laet C, Eisman J, Fujiwara S, Kroger H, McCloskey E, Mellstrom D. Smoking and fracture risk: a meta-analysis. Osteoporos Int [online]. 2005b;16(2):155–62.

    CAS  Google Scholar 

  • Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A. Alcohol intake as a risk factor for fracture. Osteoporos Int [online]. 2005c;16(7):737–42.

    Google Scholar 

  • Kanis J, Odén A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int [online]. 2007;18(8):1033–46.

    CAS  Google Scholar 

  • Kanis J, McCloskey E, Johansson H, Strom O, Borgstrom F, Odén A. Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK. Osteoporos Int [online]. 2008;19(10):1395–408.

    CAS  Google Scholar 

  • Kanis JA, Bianchi G, Bilezikian JP, Kaufman J, Khosla S, Orwoll E, Seeman E. Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int [online]. 2011;22(11):2789–98.

    CAS  Google Scholar 

  • Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD. FRAX® with and without bone mineral density. Calcif Tissue Int [online]. 2012;90(1):1–13.

    CAS  Google Scholar 

  • Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster J. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int [online]. 2013;24(1):23–57.

    CAS  Google Scholar 

  • Kearns M, Alvarez J, Tangpricha V. Large, single-dose, oral vitamin D supplementation in adult populations: a systematic review. Endocr Pract [online]. 2013;20(4):341–51.

    Google Scholar 

  • Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O’Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res [online]. 2015;30(1):3–23.

    Google Scholar 

  • Khan A, Morrison A, Cheung A, Hashem W, Compston J. Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015. Osteoporos Int [online]. 2016;27(3):853–9.

    CAS  Google Scholar 

  • Khosla S. Update in male osteoporosis. J Clin Endocrinol Metab [online]. 2010;95(1):3–10.

    CAS  Google Scholar 

  • Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res [online]. 2007;22(10):1479–91.

    Google Scholar 

  • LeBoff M, Hawkes W, Glowacki J, Yu-Yahiro J, Hurwitz S, Magaziner J. Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos Int [online]. 2008;19(9):1283–90.

    CAS  Google Scholar 

  • Lenart B, Neviaser A, Lyman S, Chang C, Edobor-Osula F, Steele B, Van Der Meulen M, Lorich D, Lane J. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int [online]. 2009;20(8):1353–62.

    CAS  Google Scholar 

  • Lewiecki EM. Bone densitometry and vertebral fracture assessment. Curr Osteoporos Rep. 2010;8(3):123–30.

    PubMed  Google Scholar 

  • Lewiecki EM, Laster AJ. Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry. J Clin Endocrinol Metab [online]. 2006;91(11):4215–22.

    CAS  Google Scholar 

  • Lewiecki E, Rudolph L. How common is loss of bone mineral density in elderly clinical practice patients receiving oral bisphosphonate therapy for osteoporosis? J Bone Miner Res [online]. 2002;17(Suppl 2):S367.

    Google Scholar 

  • Lewiecki E, Watts N. Assessing response to osteoporosis therapy. Osteoporos Int [online]. 2008;19(10):1363–8.

    CAS  Google Scholar 

  • Looker AC, Orwoll ES, Johnston CC, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res [online]. 1997;12(11):1761–8.

    CAS  Google Scholar 

  • Manolagas SC. Normal skeletal development and regulation of bone formation and resorption. May 06 2016-last update. Wolters Kluwer. 2017a. https://www.uptodate.com/contents/normal-skeletal-development-and-regulation-of-bone-formation-and-resorption?search=osteoporosis,%20pathophysiology&source=search_result&selectedTitle=4~150&usage_type=default&display_rank=4. Accessed 2 Jan 2018.

  • Manolagas SC Pathogenesis of osteoporosis. Wolters Kluwer. 2017b. https://www.uptodate.com/contents/pathogenesis-of-osteoporosis. Accessed 2 Jan 2018.

  • Manolagas SC, Parfitt AM. What old means to bone. Trends Endocrinol Metab [online]. 2010;21(6):369–74.

    CAS  Google Scholar 

  • Marbury K. Strengthening communication on bone health. GALLUB News; 2002.

    Google Scholar 

  • Melton L, Lane A, Cooper C, Eastell R, O’fallon W, Riggs B. Prevalence and incidence of vertebral deformities. Osteoporos Int [online]. 1993;3(3):113–9.

    Google Scholar 

  • National Collaborating Centre for Women’s and Children’s Health (NCCWCH) (UK). Menopause, 23. London: National Institute for Health and Care Excellence (UK); 2015.

    Google Scholar 

  • National Institute for Health and Care Excellence (NICE). Osteoporosis: assessing the risk of fragility fractures [online]. NICE CG146; 2012.

    Google Scholar 

  • O’Neill S, MacLennan A, Diamond T, Ebeling P, Findlay D, Flicker L, Markwell A, Nowson C, Pocock N, Sambrook P. Guidelines for the management of postmenopausal osteoporosis for GPs. Aust Fam Physician [online]. 2004;33:910–9.

    Google Scholar 

  • Orwig DL, Chan J, Magaziner J. Hip fracture and its consequences: differences between men and women. Orthop Clin North Am [online]. 2006;37(4):611–22.

    Google Scholar 

  • Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD, Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ [online]. 2010;182(17):1864–73.

    Google Scholar 

  • Parfitt A. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem [online]. 1994;55(3):273–86.

    CAS  Google Scholar 

  • Rabenda V, Bruyère O, Reginster J. Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression. Osteoporos Int [online]. 2011;22(3):893–901.

    CAS  Google Scholar 

  • Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Investi [online]. 2005;115(12):3318–25.

    CAS  Google Scholar 

  • Riggs BL, Melton LJ. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med [online]. 1983;75(6):899–901.

    CAS  Google Scholar 

  • Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab [online]. 2011;96(1):53–8.

    CAS  Google Scholar 

  • Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.

    Google Scholar 

  • Schousboe JT, Shepherd JA, Bilezikian JP, Baim S. Executive summary of the 2013 international society for clinical densitometry position development conference on bone densitometry. J Clin Densitom [online]. 2013;16(4):455–66.

    Google Scholar 

  • Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA [online]. 2011;305(21):2184–92.

    CAS  PubMed Central  Google Scholar 

  • Scientific Advisory Committee on Nutrition (SACN). Vitamin D and Health. London: Public Health England; 2016. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/537616/SACN_Vitamin_D_and_Health_report.pdf.

    Google Scholar 

  • Sernbo I, Johnell O. Consequences of a hip fracture: a prospective study over 1 year. Osteoporos Int [online]. 1993;3(3):148–53.

    CAS  Google Scholar 

  • Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res [online]. 2010;25(11):2267–94.

    Google Scholar 

  • Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res [online]. 2014;29(1):1–23.

    Google Scholar 

  • Stone KL, Seeley DG, Lui L, Cauley JA, Ensrud K, Browner WS, Nevitt MC, Cummings SR. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res [online]. 2003;18(11):1947–54.

    Google Scholar 

  • Ström O, Borgström F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jönsson B. Osteoporosis: burden, health care provision and opportunities in the EU. Arch Osteopor [online]. 2011;6(1–2):59–155.

    Google Scholar 

  • Svedbom A, Hernlund E, IvergÃ¥rd M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteopor [online]. 2013;8(1–2):137.

    CAS  Google Scholar 

  • Tai V, Leung W, Grey A, Reid IR, Bolland MJ. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ (Clinical research ed.) [online]. 2015;351:h4183.

    Google Scholar 

  • Takahashi M, Yamamoto Y, Kuroyanagi H, Seino Y, Kojima H. Bisphosphonate-associated ear canal osteonecrosis: a case report and review of the literature. Acta Otolaryngol Case Reports [online]. 2017;2(1):107–10.

    Google Scholar 

  • Tosteson A, Grove MR, Hammond CS, Moncur MM, Ray GT, Hebert GM, Pressman AR, Ettinger B. Early discontinuation of treatment for osteoporosis. Am J Med [online]. 2003;115(3):209–16.

    Google Scholar 

  • Tosteson AN, Melton L, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, Lindsay RL. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int [online]. 2008;19(4):437–47.

    CAS  Google Scholar 

  • US Department of Health and Human Services (USDHHS). Bone health and osteoporosis: a report of the surgeon general. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004. p. 2, 87. https://www.ncbi.nlm.nih.gov/books/NBK45513/. Accessed Jan 2018.

    Google Scholar 

  • Vasikaran S, Eastell R, Bruyère O, Foldes A, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int [online]. 2011;22(2):391–420.

    CAS  Google Scholar 

  • Watts NB. Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA). Osteoporos Int [online]. 2004;15(11):847–54.

    Google Scholar 

  • Woo S, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med [online]. 2006;144(10):753–61.

    CAS  Google Scholar 

  • World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group [meeting held in Rome from 22 to 25 June 1992]. Technical Report Series 843. Geneva: WHO; 1994. http://apps.who.int/iris/handle/10665/39142.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sherwin Criseno .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Criseno, S. (2019). Osteoporosis. In: Llahana, S., Follin, C., Yedinak, C., Grossman, A. (eds) Advanced Practice in Endocrinology Nursing. Springer, Cham. https://doi.org/10.1007/978-3-319-99817-6_53

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-99817-6_53

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-99815-2

  • Online ISBN: 978-3-319-99817-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics